Paper7340879
Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man.
Boobis AR and 6 others. Br J Clin Pharmacol, 1981. Cited by 83 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man. Papers, record 7340879. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7340879
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antipyrine | Major topic |
| Adult | |
| Aged | |
| Female | |
| Half-Life | |
| Humans | |
| Hydroxylation | |
| Kinetics | |
| Liver | |
| Male | |
| Microsomes, Liver | |
| Middle Aged | |
| Oxidation-Reduction |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5,690,279 | Genetic control of drug levels in man: antipyrine. | Science | 1968 | https://conductscience.org/library/papers/5690279 | PubMed |
| 2 | 6,766,729 | Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/6766729 | PubMed |
| 3 | 4,146,319 | Rapid gas-liquid chromatographic estimation of antipyrine in plasma. | J Pharm Pharmacol | 1973 | https://conductscience.org/library/papers/4146319 | PubMed |
| 4 | 7,362,740 | Antipyrine as an in vitro probe of mixed function oxidase activity [proceeding]. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7362740 | PubMed |
| 5 | 6,105,054 | Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo. | Drug Metab Dispos | 1980 | https://conductscience.org/library/papers/6105054 | PubMed |
| 6 | 399,809 | Multiplicity of mammalian microsomal cytochromes P-45. | Pharmacol Rev | 1979 | https://conductscience.org/library/papers/399809 | PubMed |
| 7 | 7,448,333 | An improved combined gas chromatographic mass spectrometric assay for the estimation of norphenazone in urine. | Biomed Mass Spectrom | 1980 | https://conductscience.org/library/papers/7448333 | PubMed |
| 9 | 4,356,419 | The metabolism of (ureyl-14C)tolbutamide in vitro and in vivo in man. | Life Sci | 1973 | https://conductscience.org/library/papers/4356419 | PubMed |
| 10 | 4,813,341 | Correlation of the plasma elimination of antipyrine and the appearance of 4-hydroxy antipyrine in the urine of man. | Biochem Pharmacol | 1974 | https://conductscience.org/library/papers/4813341 | PubMed |
| 11 | 4,593,769 | The effect of spironolactone on antipyrine metabolism in man. | Pharmacology | 1973 | https://conductscience.org/library/papers/4593769 | PubMed |
| 12 | 4,418,208 | Metabolism of antipyrine by the epoxide-diol pathway in the rat, guinea pig and human. | Res Commun Chem Pathol Pharmacol | 1974 | https://conductscience.org/library/papers/4418208 | PubMed |
| 13 | 4,611,464 | Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration. | Clin Pharmacol Ther | 1974 | https://conductscience.org/library/papers/4611464 | PubMed |
| 14 | 849,678 | Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine. | Clin Pharmacol Ther | 1977 | https://conductscience.org/library/papers/849678 | PubMed |
| 15 | 732,536 | Antipyrine metabolism in man. | Life Sci | 1978 | https://conductscience.org/library/papers/732536 | PubMed |
| 16 | 433,309 | Comparison of rate of hepatic metabolism in vitro and half-life for antipyrine in vivo in three species. | Xenobiotica | 1979 | https://conductscience.org/library/papers/433309 | PubMed |
| 17 | 461,498 | Assay of antipyrine and its primary metabolites in plasma, saliva and urine by high-performance liquid chromatography and some preliminary results in man. | Pharmacology | 1979 | https://conductscience.org/library/papers/461498 | PubMed |
| 18 | 111,889 | The antipyrine test in clinical pharmacology: conceptions and misconceptions. | Clin Pharmacol Ther | 1979 | https://conductscience.org/library/papers/111889 | PubMed |
| 19 | 487,696 | Drug metabolism in liver disease: activity of hepatic microsomal metabolizing enzymes. | Clin Pharmacol Ther | 1979 | https://conductscience.org/library/papers/487696 | PubMed |
| 20 | 533,575 | Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/533575 | PubMed |
| 21 | 522,906 | 4,4'-Dihydroxyphenazone as an urinary metabolite of phenazone in different species including man. | Naunyn Schmiedebergs Arch Pharmacol | 1979 | https://conductscience.org/library/papers/522906 | PubMed |
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 83 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 10,412,897 | Effect of tacrine hydrochloride on hepatic drug metabolism. | Eur J Drug Metab Pharmacokinet | 1999 | https://conductscience.org/library/papers/10412897 | PubMed |
| 8,403,737 | The relationship between phenazone (antipyrine) metabolite formation and theophylline metabolism in healthy and frail elderly women. | Clin Pharmacokinet | 1993 | https://conductscience.org/library/papers/8403737 | PubMed |
| 7,621,853 | The acetylation phenotype: does it contribute to the non-linearity of the metabolite pharmacokinetics of metamizol? | Eur J Clin Pharmacol | 1995 | https://conductscience.org/library/papers/7621853 | PubMed |
| 7,082,530 | Assay and characterisation of debrisoquine 4-hydroxylase activity of microsomal fractions of human liver. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7082530 | PubMed |
| 6,849,767 | Antipyrine metabolism in relation to polymorphic oxidations of sparteine and debrisoquine. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6849767 | PubMed |
| 6,697,063 | Tolbutamide as a model drug for the study of enzyme induction and enzyme inhibition in the rat. | Br J Pharmacol | 1984 | https://conductscience.org/library/papers/6697063 | PubMed |
| 6,639,836 | Effect of chloroquine and primaquine on antipyrine metabolism. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6639836 | PubMed |
| 6,627,809 | Interindividual variations in drug disposition. Clinical implications and methods of investigation. | Clin Pharmacokinet | 1983 | https://conductscience.org/library/papers/6627809 | PubMed |
| 6,510,457 | Antipyrine clearance in patients with Gilbert's syndrome. | Eur J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6510457 | PubMed |
| 6,508,979 | Influence of rifampicin treatment on antipyrine clearance and metabolite formation in patients with tuberculosis. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6508979 | PubMed |
| 6,487,479 | Effects of cimetidine on carbamazepine auto- and hetero-induction in man. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6487479 | PubMed |
| 6,142,865 | Noninvasive assessment of microsomal enzyme activity in occupational medicine: present state of knowledge and future perspectives. | Int Arch Occup Environ Health | 1984 | https://conductscience.org/library/papers/6142865 | PubMed |
| 6,128,018 | Assessment of the drug metabolism capacity of the liver. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6128018 | PubMed |
| 4,027,138 | Phenacetin O-deethylase: an activity of a cytochrome P-450 showing genetic linkage with that catalysing the 4-hydroxylation of debrisoquine? | Br J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/4027138 | PubMed |
| 3,994,897 | Oral morphine in cancer patients: in vivo kinetics and in vitro hepatic glucuronidation. | Br J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/3994897 | PubMed |
| 3,620,285 | The disposition of antipyrine and its metabolites in young and elderly healthy volunteers. | Br J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/3620285 | PubMed |
| 3,567,053 | Antipyrine metabolism in acute hepatic porphyria in relapse and remission. | Br J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/3567053 | PubMed |
| 3,440,100 | Disposition of antipyrine in African patients with Hodgkin's lymphoma. | Br J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/3440100 | PubMed |
| 3,402,522 | Differential effect of type I and type II diabetes on antipyrine disposition in man. | Eur J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/3402522 | PubMed |
| 3,383,988 | Selective inhibition of drug oxidation after simultaneous administration of two probe drugs, antipyrine and tolbutamide. | Eur J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/3383988 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7340879
GET https://conductscience.org/api/papers/v1/7340879/references?page=2